#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Phaeochromocytoma Inborn error of metabolism Epilepsy Dent's disease Immune thrombocytopenia Nodal marginal zone B-cell lymphoma Intracranial calcification Von Willebrand's disease Hypergammaglobulinaemia benign monoclonal Breast cancer metastatic Marfan's syndrome Immune-mediated myasthenia gravis Essential thrombocythaemia Corneal neovascularisation Chronic graft versus host disease in liver More trials…

    Learn about Rare Diseases

    Langerhans cell sarcoma Nephroblastoma – Diagnostics Lymphangioma – Diagnostics Angiosarcoma – Diagnostics Leiomyosarcoma recurrent – Trials in Disease CADASIL – Trials in Disease Short-bowel syndrome – Life with Disease Pulmonary sarcoidosis – Trials in Disease Friedreich’s ataxia – Trials in Disease Erdheim-Chester disease – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Oric-114 Ganirelix Octreotide Mbf-118 Paroxetine Hydrochloride Omalizumab Regadenoson RNK001 Gadoteridol ALE.P02 Luspatercept Dronabinol GS-1720 Orlistat GSKVX000000034797 IM-101 HAFNIUM OXIDE Ly3473329 Tradipitant MB-001 More therapies…

    Learn about Your Condition

    Transient ischaemic attack Alagille syndrome Breast proliferative changes Methylmalonic acidaemia Marfan's syndrome Iron deficiency Coronary artery bypass Rhabdomyosarcoma Sinusitis bacterial Endometrial cancer stage III Palpitations Colorectal cancer stage IV Peritoneal abscess Merycism Non-small cell lung cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cytomegalovirus infection

  • A Study of Maribavir for Cytomegalovirus Infection in Stem Cell Transplant Patients Who Cannot Take or Did Not Tolerate Standard Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    • Cytomegalovirus infection
    Investigated Drugs:
    • Maribavir
    Italy

  • Study on Preventing CMV Infection in Low-Risk Kidney Transplant Patients Using Ganciclovir and Valganciclovir

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ganciclovir
    • Valganciclovir Hydrochloride
    Spain

  • Study on Letermovir for Preventing Cytomegalovirus in Stem Cell Transplant Patients with CMV-Positive Donors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    • Cytomegalovirus infection
    Investigated Drugs:
    • Letermovir
    Spain

  • Study on Valacyclovir for Preventing and Treating Cytomegalovirus (CMV) in Pregnant Women

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cytomegalovirus infection
    Investigated Drugs:
    • Valaciclovir
    Poland

  • Study on Treating Resistant Viral Infections in Stem Cell Transplant Patients Using Allogeneic Multivirus-Specific T Cells

    Recruiting

    3 1
    Investigated Diseases:
    • Epstein-Barr virus infection
    • Adenovirus infection
    • Cytomegalovirus infection
    Investigated Drugs:
    • Allogeneic Cd4+ And Cd8+ T Lymphocytes Ex Vivo Incubated With Synthetic Peptides Of The Viral Antigens Of Cytomegalovirus, Adenovirus And Epstein-Barr Virus
    Belgium France Germany Italy The Netherlands

  • Study on Letermovir and Valganciclovir for Treating CMV Infections in Kidney Transplant Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cytomegalovirus infection
    Investigated Drugs:
    • Valganciclovir
    • Letermovir
    France
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!